Caption Management, LLC Vaxcyte, Inc. Transaction History
Caption Management, LLC
- $5.74 Billion
- Q3 2024
A detailed history of Caption Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 175,000 shares of PCVX stock, worth $16.2 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
175,000
Previous 22,500
677.78%
Holding current value
$16.2 Million
Previous $1.7 Million
1076.62%
% of portfolio
0.35%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding PCVX
# of Institutions
348Shares Held
123MCall Options Held
748KPut Options Held
411K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.06 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$1.01 Billion0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$921 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$805 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$454 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.5B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...